Prospective and interventional research on the development of a multi-scale and multi-physics cardiac simulator ped UT-Heart - ped UT-Heart

Kurosaki Kenichi0 个研究点目标入组 15 人开始时间: 2021年12月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients with pediatric congenital heart disease requiring life-sustaining cardiac repair surgery.
•(2) Patients under 15 years of age (when consent is obtained from a substitute).
•(3) Patients who need to undergo cardiac catheterization, cardiovascular angiography, and MSCT
•angiography to determine the diagnosis and treatment plan.
•(4) Patients scheduled to undergo surgery for congenital heart disease within 180 days of obtaining consent.
•(5) Patients with the following congenital heart diseases in which the three-dimensional structure of the
•heart and great vessels are extremely complicated.
•1. Double outlet right ventricle
•2. Complete transposition of the great arteries
•3. Congenitally corrected transposition of the great arteries
•4. Coarctation of aorta/ Interrupted aortic arch
•5. Ventricular septal defect with multiple defects
•6. Univentricular Heart (including complete atrioventricular septal defect with unbalanced ventricles)
•7. Tetralogy of Fallot with or without pulmonary atresia
•8. Hypoplastic left heart syndrome and its analogs

•(1) Critically ill patients who may require urgent cardiac repair surgery before the simulation using the ped
•UT-Heart system is available.
•(2) Patients who are allergic to contrast media used in MSCT and cardiac catheterization/angiography.
•(3) Patients for whom follow-up until 30 days after surgery is difficult.
•(4) Patients who are judged by the principal investigator to be unsuitable for participation in this study.

发起方

Kurosaki Kenichi